View Item 

Show simple item record

Increasing incidence of Epstein‐Barr virus–related nasopharyngeal carcinoma in the United States
dc.contributor.authorArgirion, Ilona
dc.contributor.authorZarins, Katie R.
dc.contributor.authorRuterbusch, Julie J.
dc.contributor.authorVatanasapt, Patravoot
dc.contributor.authorSriplung, Hutcha
dc.contributor.authorSeymour, Erlene K.
dc.contributor.authorRozek, Laura S.
dc.date.accessioned2020-01-13T15:12:52Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-01-13T15:12:52Z
dc.date.issued2020-01-01
dc.identifier.citationArgirion, Ilona; Zarins, Katie R.; Ruterbusch, Julie J.; Vatanasapt, Patravoot; Sriplung, Hutcha; Seymour, Erlene K.; Rozek, Laura S. (2020). "Increasing incidence of Epstein‐Barr virus–related nasopharyngeal carcinoma in the United States." Cancer (1): 121-130.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/152902
dc.publisherWiley Periodicals, Inc.
dc.publisherInternational Agency of Research on Cancer
dc.subject.otherdisparity
dc.subject.otherEpstein‐Barr virus
dc.subject.otherincidence
dc.subject.othernasopharyngeal carcinoma
dc.subject.otherSurveillance
dc.subject.otherEpidemiology
dc.subject.otherand End Results (SEER)
dc.subject.othersurvival
dc.titleIncreasing incidence of Epstein‐Barr virus–related nasopharyngeal carcinoma in the United States
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152902/1/cncr32517_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152902/2/cncr32517.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152902/3/cncr32517-sup-0001-FigS1.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152902/4/cncr32517-sup-0002-FigS2.pdf
dc.identifier.doi10.1002/cncr.32517
dc.identifier.sourceCancer
dc.identifier.citedreferenced’Amore F, Johansen P, Houmand A, Weisenburger DD, Mortensen LS. Epstein‐Barr virus genome in non‐Hodgkin’s lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T‐cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood. 1996; 87: 1045 ‐ 1055.
dc.identifier.citedreferenceHamilton‐Dutoit SJ, Pallesen G. A survey of Epstein‐Barr virus gene expression in sporadic non‐Hodgkin’s lymphomas. Detection of Epstein‐Barr virus in a subset of peripheral T‐cell lymphomas. Am J Pathol. 1992; 140: 1315 ‐ 1325.
dc.identifier.citedreferencevan Gorp J, Brink A, Oudejans JJ, et al. Expression of Epstein‐Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol. 1996; 49: 72 ‐ 76.
dc.identifier.citedreferenceOhshima K, Suzumiya J, Tasiro K, et al. Epstein‐Barr virus infection and associated products (LMP, EBNA2, vIL‐10) in nodal non‐Hodgkin’s lymphoma of human immunodeficiency virus‐negative Japanese. Am J Hematol. 1996; 52: 21 ‐ 28.
dc.identifier.citedreferenceTsuchiyama J, Yoshino T, Mori M, et al. Characterization of a novel human natural killer‐cell line (NK‐YS) established from natural killer cell lymphoma/leukemia associated with Epstein‐Barr virus infection. Blood. 1998; 92: 1374 ‐ 1383.
dc.identifier.citedreferenceKanegane H, Yachie A, Miyawaki T, Tosato G. EBV‐NK cells interactions and lymphoproliferative disorders. Leuk Lymphoma. 1998; 29: 491 ‐ 498.
dc.identifier.citedreferenceBorisch B, Hennig I, Laeng RH, Waelti ER, Kraft R, Laissue J. Association of the subtype 2 of the Epstein‐Barr virus with T‐cell non‐Hodgkin’s lymphoma of the midline granuloma type. Blood. 1993; 82: 858 ‐ 864.
dc.identifier.citedreferenceKwong YL, Chan AC, Liang RH. Natural killer cell lymphoma/leukemia: pathology and treatment. Hematol Oncol. 1997; 15: 71 ‐ 79.
dc.identifier.citedreferenceHsu JL, Glaser SL. Epstein‐Barr virus‐associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol. 2000; 34: 27 ‐ 53.
dc.identifier.citedreferenceCastillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein‐Barr virus–positive diffuse large B‐cell lymphoma of the elderly: what we know so far. Oncologist. 2011; 16: 87 ‐ 96.
dc.identifier.citedreferenceYu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case‐control study in Guangzhou, China. Int J Cancer. 1989; 43: 1077 ‐ 1082.
dc.identifier.citedreferenceCannon T, Zanation AM, Lai V, Weissler MC. Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics. Laryngoscope. 2006; 116: 1021 ‐ 1026.
dc.identifier.citedreferenceAyan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol. 2003; 4: 13 ‐ 21.
dc.identifier.citedreferenceFord JL, Stowe RP. Racial‐ethnic differences in Epstein‐Barr virus antibody titers among US children and adolescents. Ann Epidemiol. 2013; 23: 275 ‐ 280.
dc.identifier.citedreferenceDowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein‐Barr virus infection in US children ages 6‐19, 2003‐2010. PLoS One. 2013; 8: e64921.
dc.identifier.citedreferenceAlamar B, Glantz SA. Effect of increased social unacceptability of cigarette smoking on reduction in cigarette consumption. Am J Public Health. 2006; 96: 1359 ‐ 1363.
dc.identifier.citedreferenceFarrow DC, Vaughan TL, Berwick M, Lynch CF, Swanson GM, Lyon JL. Diet and nasopharyngeal cancer in a low‐risk population. Int J Cancer. 1998; 78: 675 ‐ 679.
dc.identifier.citedreferenceZou XN, Lu SH, Liu B. Volatile N‐nitrosamines and their precursors in Chinese salted fish—a possible etological factor for NPC in China. Int J Cancer. 1994; 59: 155 ‐ 158.
dc.identifier.citedreferenceJeannel D, Hubert A, De Vathaire F, et al. Diet, living conditions and nasopharyngeal carcinoma in Tunisia—a case‐control study. Int J Cancer. 1990; 46: 421 ‐ 425.
dc.identifier.citedreferenceHildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 1997; 89: 1207 ‐ 1212.
dc.identifier.citedreferenceSwann PF. Effect of ethanol on nitrosamine metabolism and distribution. Implications for the role of nitrosamines in human cancer and for the influence of alcohol consumption on cancer incidence. IARC Sci Publ. 1984; 57: 501 ‐ 512.
dc.identifier.citedreferenceInternational Agency for Research on Cancer (IARC). Alcohol Drinking. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Volume 44. IARC; 1988.
dc.identifier.citedreferenceBhattacharyya N. The impact of race on survival in nasopharyngeal carcinoma: a matched analysis. Am J Otolaryngol. 2004; 25: 94 ‐ 97.
dc.identifier.citedreferenceMa BB, Poon TC, To KF, et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma—a prospective study. Head Neck. 2003; 25: 864 ‐ 872.
dc.identifier.citedreferenceChua DT, Nicholls JM, Sham JS, Au GK. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 59: 11 ‐ 20.
dc.identifier.citedreferenceLiu W, Innocenti F, Chen P, Das S, Cook EH, Ratain MJ. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res. 2003; 9: 1009 ‐ 1012.
dc.identifier.citedreferenceLiu W, Innocenti F, Wu MH, et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 2005; 65: 46 ‐ 53.
dc.identifier.citedreferenceLeclerc A, Cortes MM, Gerin M, Luce D, Brugere J. Sinonasal cancer and wood dust exposure: results from a case‐control study. Am J Epidemiol. 1994; 140: 340 ‐ 349.
dc.identifier.citedreferenceDelzell E. Wood dust and formaldehyde. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 62. Cancer Causes Control. 1995; 6: 574 ‐ 575.
dc.identifier.citedreferenceDemers PA, Kogevinas M, Boffetta P, et al. Wood dust and sino‐nasal cancer: pooled reanalysis of twelve case‐control studies. Am J Ind Med. 1995; 28: 151 ‐ 166.
dc.identifier.citedreferenceStenmark MH, McHugh JB, Schipper M, et al. Nonendemic HPV‐positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014; 88: 580 ‐ 588.
dc.identifier.citedreferenceWong TS, Kwong DL, Sham J, Wei WI, Kwong YL, Yuen AP. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Eur J Surg Oncol. 2005; 31: 555 ‐ 558.
dc.identifier.citedreferenceBarnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumours. World Health Organization Classification of Tumours. 3rd ed. Vol. 9. International Agency of Research on Cancer; 2005.
dc.identifier.citedreferencePunwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein‐Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation‐dependent polymerase chain reaction. Head Neck. 1999; 21: 21 ‐ 29.
dc.identifier.citedreferenceOu SH, Zell JA, Ziogas A, Anton‐Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007; 18: 29 ‐ 35.
dc.identifier.citedreferenceThompson LD. Update on nasopharyngeal carcinoma. Head Neck Pathol. 2007; 1: 81 ‐ 86.
dc.identifier.citedreferenceWang Y, Zhang Y, Ma S. Racial differences in nasopharyngeal carcinoma in the United States. Cancer Epidemiol. 2013; 37: 793 ‐ 802.
dc.identifier.citedreferenceParkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol. VII. IARC Scientific Publications No. 143. International Agency for Research on Cancer; 1997.
dc.identifier.citedreferencePathmanathan R, Prasad U, Sadler R, Flynn K, Raab‐Traub N. Clonal proliferations of cells infected with Epstein‐Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995; 333: 693 ‐ 698.
dc.identifier.citedreferenceChan AS, To KF, Lo KW, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res. 2000; 60: 5365 ‐ 5370.
dc.identifier.citedreferenceChan AS, To KF, Lo KW, et al. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer. 2002; 102: 300 ‐ 303.
dc.identifier.citedreferenceFan SQ, Ma J, Zhou J, et al. Differential expression of Epstein‐Barr virus‐encoded RNA and several tumor‐related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol. 2006; 37: 593 ‐ 605.
dc.identifier.citedreferenceMimi CY, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002; 12: 421 ‐ 429.
dc.identifier.citedreferenceTricker AR, Preussmann R. Carcinogenic N‐nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutat Res. 1991; 259: 277 ‐ 289.
dc.identifier.citedreferenceVaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low‐risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev. 1996; 5: 587 ‐ 593.
dc.identifier.citedreferenceYuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, Yu MC. Non‐dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 2000; 85: 364 ‐ 369.
dc.identifier.citedreferenceYu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other non‐dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer. 1990; 45: 1033 ‐ 1039.
dc.identifier.citedreferenceNam J, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case‐control study among US whites. J Natl Cancer Inst. 1992; 84: 619 ‐ 622.
dc.identifier.citedreferenceWest S, Hildesheim A, Dosemeci M. Non‐viral risk factors for nasopharyngeal carcinoma in the Philippines: results from a case‐control study. Int J Cancer. 1993; 55: 722 ‐ 727.
dc.identifier.citedreferenceChow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. Tobacco use and nasopharyngeal carcinoma in a cohort of US veterans. Int J Cancer. 1993; 55: 538 ‐ 540.
dc.identifier.citedreferenceZhu K, Levine RS, Brann EA, Gnepp DR, Baum MK. A population‐based case‐control study of the relationship between cigarette smoking and nasopharyngeal cancer (United States). Cancer Causes Control. 1995; 6: 507 ‐ 512.
dc.identifier.citedreferenceCheng YJ, Hildesheim A, Hsu M‐M, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control. 1999; 10: 201 ‐ 207.
dc.identifier.citedreferenceGiannoudis A, Ergazaki M, Segas J, et al. Detection of Epstein‐Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Cancer Lett. 1995; 89: 177 ‐ 181.
dc.identifier.citedreferenceHording U, Nielsen HW, Daugaard S, Albeck H. Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope. 1994; 104: 99 ‐ 102.
dc.identifier.citedreferenceMaxwell JH, Kumar B, Feng FY, et al. HPV‐positive/p16‐positive/EBV‐negative nasopharyngeal carcinoma in white North Americans. Head Neck. 2010; 32: 562 ‐ 567.
dc.identifier.citedreferenceRassekh CH, Rady PL, Arany I, et al. Combined Epstein‐Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope. 1998; 108: 362 ‐ 367.
dc.identifier.citedreferenceHeck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol. 2009; 39: 166 ‐ 181.
dc.identifier.citedreferenceSurveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Populations‐Total U.S. (1969‐2016) <Katrina/Rita Adjustment>‐Linked To County Attributes‐Total U.S., 1969‐2016 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2018.
dc.identifier.citedreferenceChan J, Bray F, McCarron P, et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumours. 3rd ed. World Health Organization Classification of Tumours. IARC Press; 2005: 85 ‐ 97.
dc.identifier.citedreferenceSegi M, Kyokai NT, Igakubu TD, eds. Cancer Mortality for Selected Sites in 24 Countries. Japan Cancer Society; 1967. Accessed March 9, 2018. https://www.ncbi.nlm.nih.gov/nlmcatalog/7900272
dc.identifier.citedreferenceKim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335 ‐ 351.
dc.identifier.citedreferenceDemanelis K, Sriplung H, Meza R, et al. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population‐based analysis. Pediatr Blood Cancer. 2015; 62: 1790 ‐ 1798.
dc.identifier.citedreferenceChang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1765 ‐ 1777.
dc.identifier.citedreferenceParkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74 ‐ 108.
dc.identifier.citedreferenceBurt RD, Vaughan TL, McKnight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer. 1992; 52: 549 ‐ 556.
dc.identifier.citedreferenceFields BN, Knipe DM, Howley PM, Griffin DE. Fields Virology. 4th ed. Lippincott Williams & Wilkins; 2001.
dc.identifier.citedreferenceMiller G, Niederman JC, Andrews LL. Prolonged oropharyngeal excretion of Epstein‐Barr virus after infectious mononucleosis. N Engl J Med. 1973; 288: 229 ‐ 232.
dc.identifier.citedreferenceChen CL, Hsu MM, Hsu HC. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma. Intervirology. 1996; 39: 230 ‐ 235.
dc.identifier.citedreferenceAguilar Madrid G, Beaudry M, Bell W, et al. Statement in response to asbestos industry efforts to prevent a ban on asbestos in Pakistan: chrysotile asbestos use is not safe and must be banned. Arch Environ Occup Health. 2013; 68: 243 ‐ 249.
dc.identifier.citedreferenceTsao SW, Tsang CM, Lo KW. Epstein‐Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017; 372: 20160270.
dc.identifier.citedreferenceYoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx. 2012; 39: 137 ‐ 144.
dc.identifier.citedreferenceChien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein‐Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001; 345: 1877 ‐ 1882.
dc.identifier.citedreferencede Vathaire F, Sancho‐Garner H, de The H, et al. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow‐up study. Int J Cancer. 1988; 42: 176 ‐ 181.
dc.identifier.citedreferenceHu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein‐Barr virus BNLF‐1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol. 1991; 72: 2399 ‐ 2409.
dc.identifier.citedreferenceAbdel‐Hamid M, Chen JJ, Constantine N, Massoud M, Raab‐Traub N. EBV strain variation: geographical distribution and relation to disease state. Virology. 1992; 190: 168 ‐ 175.
dc.identifier.citedreferenceBouzid M, Djennaoui D, Dubreuil J, et al. Epstein‐Barr virus genotypes in NPC biopsies from North Africa. Int J Cancer. 1994; 56: 468 ‐ 473.
dc.identifier.citedreferenceChen ML, Tsai C, Liang CL, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein‐Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene. 1992; 7: 2131 ‐ 2140.
dc.identifier.citedreferenceMiller WE, Edwards RH, Walling DM, Raab‐Traub N. Sequence variation in the Epstein‐Barr virus latent membrane protein 1. J Gen Virol. 1994; 75: 2729 ‐ 2740.
dc.identifier.citedreferenceEdwards RH, Seillier‐Moiseiwitsch F, Raab‐Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein‐Barr virus strains. Virology. 1999; 261: 79 ‐ 95.
dc.identifier.citedreferenceCheung ST, Lo KW, Leung S, et al. Prevalence of LMP1 deletion variant of Epstein‐Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer. 1996; 66: 711 ‐ 712.
dc.identifier.citedreferenceZhang XS, Song KH, Mai HQ, et al. The 30‐bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non‐endemic areas of nasopharyngeal carcinomas in China. Cancer Lett. 2002; 176: 65 ‐ 73.
dc.identifier.citedreferenceSandvej K, Gratama JW, Munch M, et al. Sequence analysis of the Epstein‐Barr virus (EBV) latent membrane protein‐1 gene and promoter region: identification of four variants among wild‐type EBV isolates. Blood. 1997; 90: 323 ‐ 330.
dc.identifier.citedreferenceProceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein‐Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17‐24 June 1997. IARC Monogr Eval Carcinog Risks Hum. 1997; 70: 1 ‐ 492.
dc.identifier.citedreferenceThompson MP, Kurzrock R. Epstein‐Barr virus and cancer. Clin Cancer Res. 2004; 10: 803 ‐ 821.
dc.identifier.citedreferenceArber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru. High incidence of T‐cell immunophenotype and Epstein‐Barr virus infection. Am J Surg Pathol. 1993; 17: 392 ‐ 399.
dc.identifier.citedreferenceChan JK, Yip TT, Tsang WY, et al. Detection of Epstein‐Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol. 1994; 18: 938 ‐ 946.
dc.identifier.citedreferenceOtt G, Kalla J, Ott MM, Muller‐Hermelink HK. The Epstein‐Barr virus in malignant non‐Hodgkin’s lymphoma of the upper aerodigestive tract. Diagn Mol Pathol. 1997; 6: 134 ‐ 139.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr32517_am.pdf
Size:
348.8KB
Format:
PDF
View/Open
Name:
cncr32517.pdf
Size:
307.4KB
Format:
PDF
View/Open
Name:
cncr32517-sup-0001-FigS1.pdf
Size:
601.0KB
Format:
PDF
View/Open
Name:
cncr32517-sup-0002-FigS2.pdf
Size:
204.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.